These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2181355)

  • 1. Cholesterol lowering drugs.
    Amarasingham R
    N Z Med J; 1990 Mar; 103(886):138. PubMed ID: 2181355
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dichotomy between cholesterol-lowering drugs in clinical trials and practice. Experience of the DiSCO Project (District of Serra Community Control of Chronic Degenerative Diseases)].
    Volpe R; Angelico F; Ricci G; Urbinati G
    Cardiologia; 1997 Aug; 42(8):815-25. PubMed ID: 9312408
    [No Abstract]   [Full Text] [Related]  

  • 3. Statins in the prevention of coronary heart disease.
    Williamson DR; Pharand C
    Pharmacotherapy; 1998; 18(2):242-54. PubMed ID: 9545143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive lipid-lowering therapy in high-risk groups: warranted or excessive?
    Wierzbicki AS
    Int J Clin Pract; 2003 May; 57(4):256-7. PubMed ID: 12800452
    [No Abstract]   [Full Text] [Related]  

  • 5. Statin therapy for prevention of coronary artery disease with average cholesterol levels.
    Gambhir DS
    Indian Heart J; 1999; 51(1):19-20, 105. PubMed ID: 10327772
    [No Abstract]   [Full Text] [Related]  

  • 6. Secondary prevention in coronary heart disease. Fact: lowering cholesterol saves lives.
    McKenna CJ; Sugrue DD
    Ir Med J; 1995; 88(6):191. PubMed ID: 8575912
    [No Abstract]   [Full Text] [Related]  

  • 7. Reassessment of the value of lowering serum cholesterol. Questioning the wisdom of widespread intervention.
    Labreche DG
    Clin Pharm; 1988 Aug; 7(8):592-603. PubMed ID: 3048850
    [No Abstract]   [Full Text] [Related]  

  • 8. Lowering cholesterol in patients with coronary heart disease: are we ready yet?
    Barrett-Connor E
    Circulation; 1997 Dec; 96(12):4124-5. PubMed ID: 9416875
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipid lowering agents. How important are they in secondary prevention of coronary heart disease?
    Colquhoun DM
    Aust Fam Physician; 2002 Jan; 31(1):25-6, 29-30. PubMed ID: 11840884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of coronary artery disease as a result of intensive lipid-lowering therapy.
    N Engl J Med; 1991 Apr; 324(16):1133-5. PubMed ID: 2008188
    [No Abstract]   [Full Text] [Related]  

  • 11. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease.
    Marchioli R; Marfisi RM; Carinci F; Tognoni G
    Arch Intern Med; 1996 Jun; 156(11):1158-72. PubMed ID: 8639010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of cholesterol-lowering drugs United States, 1992.
    Stat Bull Metrop Insur Co; 1993; 74(4):10-7. PubMed ID: 8266279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A need to redefine the consensus on the use of statins in coronary heart disease prevention.
    Fruchart JC
    Eur Heart J; 2000 Oct; 21(19):1572-3. PubMed ID: 10988008
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical prevention of coronary heart disease through cholesterol-lowering therapy.
    Grundy SM
    Curr Ther Endocrinol Metab; 1997; 6():520-6. PubMed ID: 9174799
    [No Abstract]   [Full Text] [Related]  

  • 15. [Secondary prevention in patients with a coronary disorder: wider indication for cholesterol-lowering drugs].
    Peters RJ
    Ned Tijdschr Geneeskd; 1995 Mar; 139(12):604-6. PubMed ID: 7700402
    [No Abstract]   [Full Text] [Related]  

  • 16. [Value of determining serum cholesterol levels in patients with coronary heart disease].
    Stalenhoef AF
    Ned Tijdschr Geneeskd; 1997 Dec; 141(52):2545-8. PubMed ID: 9555153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New global standards in lipid lowering: a review of emerging evidence and concepts.
    Olsson AG; Packard C
    Int J Clin Pract Suppl; 2002 Jul; (130):2-3. PubMed ID: 12296603
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapy and clinical trials.
    Dutta-Roy AK
    Curr Opin Lipidol; 1999 Feb; 10(1):81-3. PubMed ID: 10095996
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypercholesterolemia: a reversible risk factor for coronary heart disease.
    Mishkel MA
    CMAJ; 1989 Feb; 140(4):419. PubMed ID: 2644008
    [No Abstract]   [Full Text] [Related]  

  • 20. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.